SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
-3.76%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$295M
(-24%)
Cap. Flow
-$64.3M
Cap. Flow
% of AUM
-21.79%
Top 10 Holdings %
Top 10 Hldgs %
58.84%
Holding
41
New
11
Increased
6
Reduced
13
Closed
9
Top Buys
| 1 |
AstraZeneca
AZN
|
$26.5M |
| 2 |
Pfizer
PFE
|
$15.5M |
| 3 |
Cigna
CI
|
$15.4M |
| 4 |
Merck
MRK
|
$15.4M |
| 5 |
Amgen
AMGN
|
$10.1M |
Top Sells
| 1 |
Sanofi
SNY
|
$19.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$17.8M |
| 3 |
Abbott
ABT
|
$17.5M |
| 4 |
AET
Aetna Inc
AET
|
$16.3M |
| 5 |
TG Therapeutics
TGTX
|
$12.5M |
Sector Composition
| 1 | Healthcare | 92.75% |
| 2 | Financials | 2.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AstraZeneca
AZN
$248B
| $26.5M | 8.36% |
+757,710
| New | +$26.5M |
|
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $21.3M | 6.71% |
61,720
-51,780
| -46% | -$17.8M |
|
|
3
Sanofi
SNY
$121B
| $20.5M | 6.47% |
511,446
-488,340
| -49% | -$19.6M |
|
4
Viatris
VTRS
$12.3B
| $20.3M | 6.41% |
493,820
-112,680
| -19% | -$4.64M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $15.5M | 4.91% |
92,372
+43,472
| +89% | +$7.32M |
|
|
6
Pfizer
PFE
$141B
| $15.5M | 4.88% |
+435,360
| New | +$15.5M |
|
|
7
Cigna
CI
$80.3B
| $15.4M | 4.86% |
+91,800
| New | +$15.4M |
|
|
8
Merck
MRK
$210B
| $15.4M | 4.85% |
+282,420
| New | +$15.4M |
|
9
Medtronic
MDT
$119B
| $12.8M | 4.05% |
159,850
+22,250
| +16% | +$1.78M |
|
|
ALDR
10
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $10.5M | 3.3% |
822,890
+36,020
| +5% | +$457K |
|
11
Novartis
NVS
$245B
| $10.3M | 3.25% |
127,300
-77,600
| -38% | -$6.27M |
|
|
12
Amgen
AMGN
$155B
| $10.1M | 3.19% |
+59,300
| New | +$10.1M |
|
13
Ironwood Pharmaceuticals
IRWD
$214M
| $10M | 3.16% |
649,824
-798,976
| -55% | -$12.3M |
|
14
Dr. Reddy's Laboratories
RDY
$11.8B
| $9.65M | 3.04% |
+295,132
| New | +$9.65M |
|
15
CVS Health
CVS
$92.8B
| $7.52M | 2.37% |
120,830
-194,670
| -62% | -$12.1M |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $7.42M | 2.34% |
43,900
-96,300
| -69% | -$16.3M |
|
|
17
TG Therapeutics
TGTX
$4.65B
| $6.76M | 2.13% |
475,918
-879,260
| -65% | -$12.5M |
|
18
MiMedx Group
MDXG
$1.05B
| $6.29M | 1.98% |
902,100
+175,800
| +24% | +$1.23M |
|
|
ELGX
19
DELISTED
Endologix Inc
ELGX
| $5.57M | 1.76% |
1,316,912
-879,313
| -40% | -$3.72M |
|
20
United Therapeutics
UTHR
$13.8B
| $5.28M | 1.67% |
+47,000
| New | +$5.28M |
|
|
NXTM
21
DELISTED
NxStage Medical Inc.
NXTM
| $5.18M | 1.64% |
208,480
-4,720
| -2% | -$117K |
|
22
Bristol-Myers Squibb
BMY
$96B
| $5.16M | 1.63% |
+81,600
| New | +$5.16M |
|
|
SIEN
23
DELISTED
Sientra, Inc.
SIEN
| $5.11M | 1.61% |
529,210
+44,603
| +9% | +$431K |
|
|
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.04M | 1.59% |
+127,564
| New | +$5.04M |
|
25
Cencora
COR
$56.5B
| $4.97M | 1.57% |
+57,600
| New | +$4.97M |
|